A detailed history of Wellington Management Group LLP transactions in Evolus, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 175,039 shares of EOLS stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175,039
Previous 134,324 30.31%
Holding current value
$2.45 Million
Previous $1.46 Million 94.58%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.66 - $17.48 $434,021 - $711,698
40,715 Added 30.31%
175,039 $2.84 Million
Q2 2024

Aug 13, 2024

BUY
$10.45 - $13.76 $95,429 - $125,656
9,132 Added 7.29%
134,324 $1.46 Million
Q1 2024

May 15, 2024

BUY
$9.99 - $14.91 $1.25 Million - $1.87 Million
125,192 New
125,192 $1.75 Million
Q4 2023

Feb 12, 2024

BUY
$7.6 - $10.53 $494,182 - $684,702
65,024 New
65,024 $684,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $784M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.